McKesson Corp. (NYSE: MCK) Q2 2021 earnings call dated Nov. 03, 2020 Corporate Participants: Holly Weiss -- Senior Vice President, Investor Relations Brian S.
McKesson Corp. (MCK) Q2 2021 Earnings Call Transcript
Categories
Health Care
AbbVie (ABBV) to focus more on pipeline as recovery gathers pace
AbbVie, Inc. (NYSE: ABBV) has been recovering steadily from the virus-related slowdown and latest statistics show that the company's performance has improved
Eagle Pharmaceuticals Inc. (EGRX) Q3 2020 Earnings Call Transcript
Eagle Pharmaceuticals Inc. (NASDAQ: EGRX) Q3 2020 Earnings Call dated Nov. 02, 2020 Corporate Participants: Lisa M. Wilson -- Investor Relations - In-Site Communications,
AbbVie Inc. (ABBV) Q3 2020 Earnings Call Transcript
AbbVie Inc. (NYSE: ABBV) Q3 2020 earnings call dated Oct. 30, 2020 Corporate Participants: Liz Shea -- Investor Relations Richard A. Gonzalez -- Chairman of the
AbbVie shares gain after Q3 results beat estimates: Infographic
AbbVie (NYSE: ABBV) reported third-quarter 2020 financial results before the regular trading hours on Friday. The pharmaceutical behemoth reported Q3 revenue of
Illumina Inc. (ILMN) Q3 2020 Earnings Call Transcript
Illumina Inc. (NASDAQ: ILMN) Q3 2020 earnings call dated Oct. 29, 2020 Corporate Participants: Juliet Cunningham -- Vice President, Investor Relations Francis deSouza -- President and
SingleCare deal aimed at growing subscribers: Trxade CEO Suren Ajjarapu
Trxade (NASDAQ: MEDS) may have been on a dream run of late due to the strong demand for PPE, but the drug
Moderna Inc. (MRNA) Q3 2020 Earnings Call Transcript
Moderna Inc. (NASDAQ: MRNA) Q3 2020 earnings call dated Oct. 29, 2020 Corporate Participants: Lavina Talukdar -- Senior Vice President & Head of Investor
Moderna reports higher earnings, wider loss in Q3
Moderna Inc (NASDAQ: MRNA) reported third-quarter 2020 financial results before the opening bell on Thursday. The frontrunner in COVID vaccine research reported
Amgen Inc. (AMGN) Q3 2020 Earnings Call Transcript
Amgen Inc. (NASDAQ: AMGN) Q3 2020 earnings call dated Oct. 28, 2020 Corporate Participants: Arvind Sood -- Vice President of Investor Relations Robert A. Bradway -- Chairman
Infographic: Highlights of Gilead Sciences (GILD) Q3 earnings report
Biopharmaceutical company Gilead Sciences Inc (NASDAQ: GILD) Wednesday said its third-quarter earnings increased, aided by higher revenues. The results also exceeded the
Centene Corp. (CNC) Q3 2020 Earnings Call Transcript
Centene Corp. (NYSE: CNC) Q3 2020 earnings call dated Oct. 27, 2020 Corporate Participants: Jennifer Gilligan -- Senior Vice President, Finance & Investor Relations
Eli Lilly and Company (LLY) Q3 2020 Earnings Call Transcript
Eli Lilly and Company (NYSE : LLY) Q3 2020 earnings call dated Oct. 27, 2020 Corporate Participants: Kevin Hern -- Vice President, Investor Relations
Pfizer Inc (PFE) Q3 2020 Earnings Call Transcript
Pfizer Inc. (NYSE: PFE) Q3 2020 Earnings Call dated Oct. 27, 2020. Corporate Participants: Chuck Triano -- Senior Vice President, Investor Relations Albert Bourla -- Chairman
Laboratory Corp Of America Holdings (LH) Q3 2020 Earnings Call Transcript
Laboratory Corp Of America Holdings (NYSE: LH) Q3 2020 earnings call dated Oct. 27, 2020 Corporate Participants: Clarissa Willett -- Vice President, Investor Relations
Merck & Co. Inc. (MRK) Q3 2020 Earnings Call Transcript
Merck & Co. Inc. (NYSE: MRK) Q3 2020 earnings call dated Oct. 27, 2020 Corporate Participants: Peter Dannenbaum -- Vice President, Investor Relations Kenneth
Pfizer (PFE) posts mixed results in Q3
Pfizer Inc (NYSE: PFE) reported third-quarter 2020 financial results before the opening bell on Tuesday. The pharmaceutical giant reported a 4% decline
Infographic: Highlights of Merck & Co. (MRK) Q3 2020 earnings report
Merck & Co., Inc. (NYSE: MRK) reported stronger than expected earnings and sales for the third quarter of 2020. The company's stock
Trxade Group Inc. (MEDS) Q3 2020 Earnings Call Transcript
Trxade Group Inc. (NASDAQ: MEDS) Q3 2020 earnings call dated Oct. 26, 2020 Corporate Participants: Howard Doss -- Chief Financial Officer Suren Ajjarapu -- Chief Executive
Trxade (MEDS) delivers another quarter of strong revenue growth
Trxade (NASDAQ: MEDS) on Monday posted a 174% increase in third-quarter revenues to $6.3 million, riding on continued strength in PPE sales.
Quest Diagnostics, Inc. (DGX) Q3 2020 Earnings Call Transcript
Quest Diagnostics, Inc. (NYSE: DGX) Q3 2020 earnings call dated Oct. 22, 2020 Corporate Participants: Shawn Bevec -- Vice President of Investor Relations Stephen